| Literature DB >> 27924322 |
D Montagner1, B Fresch2, K Browne3, V Gandin4, A Erxleben3.
Abstract
A new Cu-based anticancer metallodrug which targets the translocator protein is reported. [CuBr2(TZ6)] elicits a remarkable in vitro cytotoxicity in sensitive and multidrug resistant cell lines and induces a 98% reduction of tumor mass in a murine tumor model. Target binding was studied by experimental and computational methods.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27924322 DOI: 10.1039/c6cc08100b
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222